The chronic lymphocytic leukemia microenvironment: Beyond the B-cell receptor

Area of Science:

• Oncology
• Immunology
• Hematology

Background:

• Malignant B cells in chronic lymphocytic leukemia (CLL) infiltrate blood, bone marrow, and lymphoid organs.
• CLL cells establish a protective tumor microenvironment by interacting with normal cellular and molecular components.
• Therapeutic strategies targeting these microenvironmental interactions demonstrate significant efficacy in CLL pathogenesis.

Purpose of the Study:

• To review the key cellular components, soluble factors, and signaling pathways within the CLL microenvironment.
• To highlight recent clinical advancements in targeting the CLL microenvironment.
• To focus on aspects of the microenvironment beyond the well-established B cell receptor (BCR) pathway.

Main Methods:

• Literature review of cellular components in the CLL microenvironment.
• Analysis of soluble factors contributing to the CLL microenvironment.
• Review of signaling pathways implicated in CLL pathogenesis.
• Summary of recent clinical trial data and therapeutic advances.

Main Results:

• The CLL microenvironment comprises various cellular elements and soluble factors that support malignant B cell survival and proliferation.
• Signaling pathways distinct from BCR are crucial for maintaining the protective niche.
• Targeting these non-BCR pathways and immune modulators represents a promising therapeutic avenue.

Conclusions:

• The CLL microenvironment is a complex ecosystem critical for disease progression.
• Modulating the microenvironment beyond BCR signaling offers novel therapeutic opportunities for chronic lymphocytic leukemia.
• Further research into these interactions will drive the development of next-generation CLL treatments.